1. Home
  2. ICCC vs FEAM Comparison

ICCC vs FEAM Comparison

Compare ICCC & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • FEAM
  • Stock Information
  • Founded
  • ICCC 1982
  • FEAM 2016
  • Country
  • ICCC United States
  • FEAM United States
  • Employees
  • ICCC N/A
  • FEAM N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • FEAM Major Chemicals
  • Sector
  • ICCC Health Care
  • FEAM Industrials
  • Exchange
  • ICCC Nasdaq
  • FEAM Nasdaq
  • Market Cap
  • ICCC 60.1M
  • FEAM 70.5M
  • IPO Year
  • ICCC 1987
  • FEAM N/A
  • Fundamental
  • Price
  • ICCC $6.46
  • FEAM $3.81
  • Analyst Decision
  • ICCC
  • FEAM Strong Buy
  • Analyst Count
  • ICCC 0
  • FEAM 2
  • Target Price
  • ICCC N/A
  • FEAM $121.00
  • AVG Volume (30 Days)
  • ICCC 16.1K
  • FEAM 24.6K
  • Earning Date
  • ICCC 08-14-2025
  • FEAM 09-03-2025
  • Dividend Yield
  • ICCC N/A
  • FEAM N/A
  • EPS Growth
  • ICCC N/A
  • FEAM N/A
  • EPS
  • ICCC N/A
  • FEAM N/A
  • Revenue
  • ICCC $27,302,766.00
  • FEAM N/A
  • Revenue This Year
  • ICCC N/A
  • FEAM N/A
  • Revenue Next Year
  • ICCC N/A
  • FEAM N/A
  • P/E Ratio
  • ICCC N/A
  • FEAM N/A
  • Revenue Growth
  • ICCC 28.29
  • FEAM N/A
  • 52 Week Low
  • ICCC $3.34
  • FEAM $2.82
  • 52 Week High
  • ICCC $7.60
  • FEAM $24.84
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 47.42
  • FEAM 49.11
  • Support Level
  • ICCC $6.25
  • FEAM $3.81
  • Resistance Level
  • ICCC $7.30
  • FEAM $5.15
  • Average True Range (ATR)
  • ICCC 0.34
  • FEAM 0.36
  • MACD
  • ICCC -0.03
  • FEAM 0.06
  • Stochastic Oscillator
  • ICCC 20.00
  • FEAM 22.99

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

Share on Social Networks: